Co-Authors
This is a "connection" page, showing publications co-authored by Fengyu Hu and Linghua Li.
Connection Strength
1.181
-
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China. J Clin Virol. 2020 12; 133:104661.
Score: 0.227
-
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020 11; 17(11):1119-1125.
Score: 0.227
-
Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients. Virology. 2020 12; 551:26-35.
Score: 0.226
-
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. J Med Virol. 2021 02; 93(2):794-802.
Score: 0.224
-
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18; 1(1):105-113.e4.
Score: 0.221
-
Prognostic Factors for COVID-19 Pneumonia Progression to Severe Symptoms Based on Earlier Clinical Features: A Retrospective Analysis. Front Med (Lausanne). 2020; 7:557453.
Score: 0.057